Brief: Shilpa Medicare Completes Phase 1 Clinical Trial For Recombinant Human Albumin 20%
07/08/2024 07:29
Aug 7 (Reuters) - Shilpa Medicare Ltd SHME.NS :
* SUCCESSFUL COMPLETION OF PHASE 1 CLINICAL TRIAL FOR
RECOMBINANT
HUMAN ALBUMIN 20%
Source text for Eikon: ID:nBSE3QX7Wx
Further company coverage: SHME.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026